Monitoring of vancomycin in pediatrics;Suivi des concentrations sériques de la vancomycine en pédiatrie

Medecine et Maladies Infectieuses

Volumn 42, Issue 4, 2012, Pages 167-170

  Delicourt, A ^a   Touzin, K ^a   Lavoie, A ^a   Therrien, R ^a   Lebel, D ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Dosage antibiotique; P diatrie; Vancomycine

Indexed keywords

VANCOMYCIN;

ARTICLE; CHILD CARE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG MONITORING; HUMAN; MEDICAL PRACTICE; PEDIATRICS; PRESCRIPTION; RETROSPECTIVE STUDY;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; DRUG PRESCRIPTIONS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; QUEBEC; RETROSPECTIVE STUDIES; VANCOMYCIN;

EID: 84861194077     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2012.02.001     Document Type: Article

References (10)

1. Rybak M., Lomaestro B., Rotschafer J.C., Moellering R., Craig W., Billeter M., et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 2009, 66(1):82-98.
2. Miles M.V., Li L., Lakkis H., Youngblood J., McGinnis P. Special considerations for monitoring vancomycin concentrations in pediatric patients. Ther Drug Monit 1997, 19(3):265-270.
3. Garrelts J.C., Godley P.J., Horton M.W., Karboski J.A. Accuracy of Bayesian, Sawchuk-Zaske, and nomogram dosing methods for vancomycin. Clin Pharm 1987, 6(10):795-799.
4. Tan W.H., Brown N., Kelsall A.W., McClure R.J. Dose regimen for vancomycin not needing serum peak levels?. Arch Dis Child Fetal Neonatal Ed 2002, 87(3):F214-F216.
5. Crumby T., Rinehart E., Carby M.C., Kuhl D., Talati A.J. Pharmacokinetic comparison of nomogram-based and individualized vancomycin regimens in neonates. Am J Health Syst Pharm 2009, 66(2):149-153.
6. de Hoog M., Schoemaker R.C., Mouton J.W., van den Anker J.N. Vancomycin population pharmacokinetics in neonates. Clin Pharmacol Ther 2000, 67(4):360-367.
7. Thomas M.P., Steele R.W. Monitoring serum vancomycin concentrations in children: is it necessary?. Pediatr Infect Dis J 1998, 17(4):351-353.
8. Lodise T.P., Patel N., Lomaestro B.M., Rodvold K.A., Drusano G.L. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Clin Infect Dis 2009, 49(4):507-514.
9. Alfandari S., Levent T., Descamps D., Hendricx S., Bonenfant C., Taines V., et al. Evaluation of glycopeptides use in nine French hospitals. Med Mal Infect 2010, 40(4):232-237.
10. Glover M.L., Cole E., Wolfsdorf J. Vancomycin dosage requirements among pediatric intensive care unit patients with normal renal function. J Crit Care 2000, 15(1):1-4.